NCT06387849

Brief Summary

A prospective randomized triple blinded study conducted in the obstetrics gynecology department of Ben Arous hospital over a period of four months and 10 days between April 2023 and August 2023. The aim of this study was to evaluate the effectiveness of lavender aromatherapy on postoperative pain and anxiety after cesarean section under spinal anesthesia in Tunisian women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 21, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 20, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 29, 2024

Completed
Last Updated

April 29, 2024

Status Verified

April 1, 2024

Enrollment Period

4 months

First QC Date

April 20, 2024

Last Update Submit

April 24, 2024

Conditions

Keywords

CesareanPainAnxietyAromatherapyLavender

Outcome Measures

Primary Outcomes (2)

  • Post-operative pain level

    the investigator evaluated the Post-operative pain level using Visual analogue scale( patient at rest and after ambulation). The score ranges from 0 (no pain at all) to 10 (the worst imaginable pain). the higher the score is, the worst the outcome is.

    two to twelve hours after surgery

  • Post-operative anxiety level

    the investigator evaluated the Post-operative anxiety level using the " State Trait Anxiety Inventory (STAI)forme Y ". The score ranges from 20 to 80. Higher scores are associated with higher levels of anxiety (worse outcome)

    two to twelve hours after surgery

Secondary Outcomes (5)

  • Heart Rate (HR)

    two to twelve hours after surgery

  • Systolic Blood Pressure (SBP)

    two to twelve hours after surgery

  • Diastolic Blood Pressure (DBP)

    two to twelve hours after surgery

  • Respiratory Rate (RR)

    two to twelve hours after surgery

  • Pulsatile Oxygen Saturation

    two to twelve hours after surgery

Study Arms (2)

Aromatherapy group

EXPERIMENTAL

Two to twelve hours after undergoing C-section, the women enrolled in the experimental arm benefited from aromatherapy with lavender essential oil (EO): The patients were invited to inhale cotton balls, soaked separately with three drops of the EO at a distance of 10 centimeters for 30 minutes.

Other: Aromatherapy

Placebo

PLACEBO COMPARATOR

Two to twelve hours after undergoing C-section, the women enrolled in the placebo arm were invited to inhale cotton balls, soaked separately with three drops of the distilled water at a distance of 10 centimeters for 30 minutes.

Other: Placebo

Interventions

women enrolled in the experimental group received aromatherapy with lavender essential oil (EO) through dry inhalation (inhalation via a cotton support soaked in a few drops of EO)

Aromatherapy group
PlaceboOTHER

women enrolled in the placebo group received ihaled a cotton support soaked in a few drops of distilled water

Placebo

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All women who gave birth by cesarean section under spinal anesthesia in the obstetrics and gynecology department at the Ben Arous regional hospital who met the following criteria were included in this study:
  • Age between 18 and 45 years old
  • Term of pregnancy at the time of delivery ≥ 37 weeks of Gestation.
  • A minimum level of primary education as a prerequisite to answer the questions (in particular the STAI items).
  • Classified ASA 1 or 2 of the American Society of Anesthesiology (ASA) classification.
  • Having no history of cancer or chronic pain.
  • Free from any psychiatric pathology.
  • And having not presented any intra- or post-operative complications.

You may not qualify if:

  • The investigators excluded patients in our study:
  • Having given birth to a stillborn or a suffering newborn requiring transfer to neonatal intensive care.
  • Having received painkillers in the post-operative period.
  • Having olfactory disorders.
  • Having a substance abuse problem.
  • Having a known allergy to lavender or other aromatic plants.
  • who did not agree to participate in the study or who did not continue all stages of the trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ben Arous Regional Hospital

Ben Arous, Tunisia

Location

Related Publications (1)

  • Nouira M, Souayeh N, Kanzari SA, Rouis H, Lika A, Mbarki C, Rahali FZ, Bettaieb H. Aromatherapy Using Lavender Oil Effectiveness on Pain and Anxiety After C-Section: A Randomized Controlled Trial. J Epidemiol Glob Health. 2024 Dec;14(4):1536-1544. doi: 10.1007/s44197-024-00305-6. Epub 2024 Oct 14.

MeSH Terms

Conditions

Pain, PostoperativePainAnxiety Disorders

Interventions

Aromatherapy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPhytotherapySensory Art TherapiesPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Hajer Bettaieb, Professor

    University of Tunis el Manar, Faculty of medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated Professor

Study Record Dates

First Submitted

April 20, 2024

First Posted

April 29, 2024

Study Start

April 21, 2023

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

April 29, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations